In people using Zepbound, hair loss occurred more frequently in females (7.1%) than in males (0.5%), but no patients using Zepbound stopped studies due to hair loss
Obesity advocacy is gaining ground in Texas In May of 2025, the Obesity Action Coalition (OAC) and the American Diabetes Association (ADA) celebrated bipartisan movement in the Texas Legislature on House Bill 2677, which proposed Medicaid coverage for FDA-approved anti-obesity medications, intensive behavioral therapy, and bariatric surgery
it helps patients consume less food, leading to weight loss
GLP-1R is expressed in various brain regions, including the hypothalamus, cortex, and hippocampus, as well as peripheral nervous tissues [6]
Source: Daily Mail 4
avoid lying down after meals